Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. (KYTX) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)
About this filing
Kyverna Therapeutics, Inc. (KYTX) filed Form SCHEDULE 13G/A (ownership over 5% (passive) (amendment)) with the SEC on Aug 14, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More KYTX filings
- 10-Q
Filed Nov 12, 2026
- 8-K
Filed Nov 12, 2026
- SC 13G
Filed Oct 19, 2026
- 8-K
Filed Sep 24, 2026
- 10-Q
Filed Aug 11, 2026
- 8-K
Filed Aug 11, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.